(lp0
S'Clovis Oncology Stock-Drop Claims Still Fall Short, Court Told Law360  - Mar 20, 2017 Law360, New York  -- Three underwriters accused of helping Clovis Oncology Inc. defraud investors in a stock offering asked a Colorado federal court Friday to dismiss claims against them, saying changes that were supposed&nbsp;...'
p1
aS"Hot Stock Update: Clovis Oncology, Inc.  HugoPress - 15 hours ago Chardan Capital Downgrades Clovis Oncology, Inc. 's stock to Sell with the price target of $36. This rating was issued on 2/03/17."
p2
aS'JP Morgan Boosts Price Target for Clovis Oncology Inc  on Back of ... Smarter Analyst - Feb 23, 2017 J.P. Morgan analyst Cory Kasimov is out with a new research report on shares of Neutral-rated Clovis Oncology Inc , raising the price target to $58 , after the drug maker released its fourth-quarter results, which provided some ...Commit To Purchase Clovis Oncology At $35, Earn 12.3% Using Options - NasdaqClovis Oncology Announces 2016 Operating Results - Yahoo Finance'
p3
aS"Apple, Netflix, Clovis Oncology Upgraded Schaeffers Research  - Mar 15, 2017 Analysts are weighing in on iPhone maker Apple Inc. , &quot;FANG&quot; stock Netflix, Inc. , and cancer treatment specialist Clovis Oncology Inc . Here's a quick roundup of today's bullish brokerage notes on AAPL,&nbsp;...Analyst Activity  Goldman Sachs Group Inc Raises Its Price Target On Clovis ... - Market ExclusiveClovis Oncology Inc  Trading Up 5.8% on Analyst Upgrade - Chaffey Breeze"
p4
aS"Option Market Alert: Clovis Oncology Inc Implied Price Swing Hits An Unsually ... CML News - Mar 19, 2017 Risk Alert: Before we dive into any analysis we simply note that Clovis Oncology Inc  risk is elevated. We'll detail it below -- but that's the lede -- the option market is starting to flash those neon lights that signal &quot;risk is rising ...Clovis Oncology Inc  Earns Hold Rating from JPMorgan Chase &amp; Co. - Chaffey BreezeThe Clovis Oncology Inc  Rating Reiterated by Chardan Capital - Petro Global News 24"
p5
aS"Clovis Oncology Presents New Data from Phase 2 Studies of Rucaparib in ... Yahoo Finance - Mar 12, 2017 Clovis Oncology, Inc.  announced new data from parts 1 and 2 of the ongoing ARIEL2 Phase 2 study being presented today at the 2017 Society of Gynecologic Oncology  Annual Meeting on Women's Cancer in National Harbor, MD."
p6
aS'The Federated Investors Inc. PA Purchases Shares of 14423 Clovis Oncology Inc ... Petro Global News 24 - 20 hours ago Federated Investors Inc. PA purchased a new stake in Clovis Oncology Inc  during the fourth quarter, Holdings Channel reports.Clovis Oncology Inc.  Plunges 7.78% on March 21 - Equities.comClovis Oncology  Reaches $67.48 After 9.00% Up Move; Putnam Managed ... - Herald KS'
p7
aS'Clovis Oncology Inc Risk Points versus Health Care CML News - Mar 8, 2017 This is a scatter plot analysis of the critical risk points from the option market for Clovis Oncology Inc  compared to its own past and the Health Care ETF.Traders Secrets on Telephone and Data Systems, Inc. , Clovis Oncology ... - StockNewsJournalCompany Performance of Clovis Oncology, Inc.  Increases 7.37% - Times Money'
p8
aS'Buy, Sell or Hold? Analysts Approach: Scientific Games Corporation (SGMS ... The USA Commerce - Mar 21, 2017 While trading at volume below than average, Clovis Oncology, Inc.  previous 52-week high was $74.94 and moved up 260.34% over the same period, trading at a volume of 1.57 million.'
p9
aS"Average Brokerage Rating Of Nivalis Therapeutics, Inc. , Clovis Oncology ... The USA Commerce - Mar 15, 2017 Shares of Nivalis Therapeutics, Inc.  surged 1.37% to $2.96. During the trading on 03/14/2017, Company's stock ranged from $2.92 to $3.63."
p10
a.